Human Melioidosis
Author(s) -
Ian Gassiep,
Mark Armstrong,
Robert Norton
Publication year - 2020
Publication title -
clinical microbiology reviews
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 9.177
H-Index - 282
eISSN - 1070-6305
pISSN - 0893-8512
DOI - 10.1128/cmr.00006-19
Subject(s) - melioidosis , burkholderia pseudomallei , pneumonia , immunology , medicine , intensive care medicine , biology , outbreak , microbiology and biotechnology , pathology , bacteria , genetics
The causative agent of melioidosis,Burkholderia pseudomallei , a tier 1 select agent, is endemic in Southeast Asia and northern Australia, with increased incidence associated with high levels of rainfall. Increasing reports of this condition have occurred worldwide, with estimates of up to 165,000 cases and 89,000 deaths per year. The ecological niche of the organism has yet to be clearly defined, although the organism is associated with soil and water. The culture of appropriate clinical material remains the mainstay of laboratory diagnosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom